EMEA-000828-PIP01-09-M07

Key facts

Invented name
Jardiance
Active substance
empagliflozin
Therapeutic area
Endocrinology, -gynacology-fertility-metabolism
Decision number
P/0201/2018
PIP number
EMEA-000828-PIP01-09-M07
Pharmaceutical form(s)
Film-coated tablets
Condition(s) / indication(s)
Treatment of type-2 diabetes mellitus
Route(s) of administration
Oral use
Contact for public enquiries
Boehringer Ingelheim International GmbH
Tel. +49 6132 778271
E-mail: paediatrics@boehringer-ingelheim.com
Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating